Balloon Angioplasty
Orbital atherectomy not superior to balloon angioplasty for treatment of certain lesions
WASHINGTON — In patients with severely calcified coronary lesions eligible for either treatment, orbital atherectomy did not improve clinical or imaging outcomes compared with conventional balloon angioplasty, researchers reported.
Q&A: ‘First of its kind’ stent for neonates, very young with pulmonary stenosis approved
In August, the FDA approved a novel miniaturized cardiac stent for infants and small children with coarctation of the aorta or pulmonary artery stenosis and can be expanded as they grew.
Studies demonstrate benefits of OCT guidance over angiography for PCI
In two trials, OCT-guided PCI demonstrated superiority in imaging endpoints and improved procedural success compared with angiography and fluoroscopy alone, speakers reported.
Ultrasound-guided angioplasty beneficial in symptomatic peripheral artery disease
ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.
FDA approves low-profile balloon expandable stent
W. L. Gore and Associates announced the FDA approved of its low-profile balloon expandable stent for treatment of iliac artery de novo or restenotic lesions with reference vessel diameters of 5 to 13 mm and lesion length up to 110 mm.
LIFE-BTK trial: Bioresorbable scaffold did not disrupt wound healing in patients with CLTI
An everolimus-eluting bioresorbable scaffold did not affect wound healing compared with angioplasty in patients with chronic limb-threatening ischemia, according to new data from the LIFE-BTK trial.
Revascularization after treatment of in-stent restenosis high after 10 years
SAN FRANCISCO — Among patients treated for drug-eluting in-stent restenosis, the revascularization rate at 10 years was high, according to the results of a post hoc analysis of the ISAR-DESIRE 3 trial presented at TCT 2023.
Drug-coated balloon bests uncoated balloon for coronary in-stent restenosis in AGENT IDE trial
SAN FRANCISCO — A paclitaxel-coated balloon was superior to conventional balloon angioplasty for treatment of coronary in-stent restenosis, according to the results of the AGENT IDE trial presented at TCT 2023.
Bioresorbable scaffold superior to angioplasty for treating chronic limb-threatening ischemia
SAN FRANCISCO — An everolimus-eluting bioresorbable scaffold was superior to angioplasty for the treatment of patients with chronic limb-threatening ischemia, according to the results of the LIFE-BTK trial presented at TCT 2023.
Balloon angioplasty, stent procedures safe soon after pediatric congenital heart surgery
Balloon angioplasty and stent implantation procedures in the early postoperative period after congenital heart surgery are overall relatively safe and effective, data from a retrospective, single-center study show.